BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UM//UM*Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Detroit
TZURL:http://tzurl.org/zoneinfo/America/Detroit
X-LIC-LOCATION:America/Detroit
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20070311T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20071104T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20251024T114919
DTSTART;TZID=America/Detroit:20251113T150000
DTEND;TZID=America/Detroit:20251113T163000
SUMMARY:Lecture / Discussion:McKesson Foundation Health Equity Speaker Series: Utibe R. Essien\, MD\, MPH
DESCRIPTION:McKesson Foundation Health Equity Speaker Series: Utibe R. Essien\, MD\, MPH\nDate: Thursday November 13\, 2025\nTime: 3:00 pm – 4:30 pm\nLocation: Palmer Commons\, Great Lakes Room\, 100 Washtenaw Ave\, Ann Arbor\, MI 48109\nTitle: Pursuing Pharmacoequity: A Prescription for Health\n\nThis event is free of cost. Refreshments will be provided. RSVP is requested to aid in an accurate headcount for catering. Please help us be good stewards of University resources and update your response if plans change.\n\nCoined by Utibe R. Essien\, MD\, MPH\, pharmacoequity is defined as “ensuring all individuals\, regardless of race and ethnicity\, socioeconomic status\, or availability of resources\, have access to the highest-quality medications required to manage their health needs.”. The goal of this talk is to explain the concept of pharmacoequity and how individuals can apply this knowledge to their practice and communities.\n\nSpeaker\nUtibe R. Essien\, MD\, MPH\nAssistant Professor of Medicine\, David Geffen School of Medicine\, University of California Los Angeles\; Associate Vice Chair\, Community Engagement and Inclusive Excellence\, Department of Medicine\n\nBiography\nUtibe R. Essien\, MD\, MPH\, FACP is a board-certified\, internal medicine physician\, an Assistant Professor of Medicine and health equity researcher at the David Geffen School of Medicine at UCLA. A proud New Yorker\, Dr. Essien received his MD from the Albert Einstein College of Medicine in the Bronx\, NY before training in internal medicine at Massachusetts General Hospital (MGH) and Harvard Medical School. After residency he remained at MGH to complete a General Internal Medicine fellowship and receive an MPH degree from the Harvard School of Public Health.\n\nDr. Essien’s research focuses on disparities in the use of novel medications and technologies\, particularly in the management of cardiovascular diseases. In 2021\, he coined the term “pharmacoequity\,” providing a new framework to achieving equitable access to care. He is an emerging leader in the field\, as recognized by over 120 peer-reviewed publications and research grants from the Department of Veterans Affairs and the American Heart Association. His research has earned him numerous national awards including a 2023 Young Physician Scientist Award from the American Society for Clinical Investigation (ASCI)\, the 2024 Society of General Internal Medicine (SGIM) Outstanding Junior Investigator of the Year Award\, and selection as an Emerging Leader in Health and Medicine by the National Academy of Medicine (NAM).\n\nMcKesson Foundation Health Equity Speaker Series\n\nDisparities in health and healthcare have been are prevalent\, particularly in underserved or minority communities\, as a result of a variety of factors such as birthplace\, housing\, education\, race\, age\, sexual identity and other nonmedical factors. These factors are commonly referred to as the social determinants of health (SDOH). As a result of SDOH\, quality healthcare and treatment can be difficult to access for many who don’t fall into the dominant group and must confront barriers to receive treatment.\n\nExamples of barriers to adequate healthcare treatment include poverty\, lack of access to quality education or positive social activities\, and unhealthy environmental factors. These factors must be addressed in order to achieve positive health outcomes and equity in access to healthcare and treatment for all. To help illuminate and educate around issues involving social determinants of health\, the College of Pharmacy and the McKesson Foundation have teamed up to launch the McKesson Foundation Health Equity Speaker Series.\n\nFor the past two years the College of Pharmacy at the University of Michigan in partnership with the McKesson Foundation has hosted a speaker series based on the topic of health equity. The McKesson Foundation is dedicated to advancing health outcomes for all with the mission to removing barriers to quality healthcare across the country\, especially for vulnerable and underserved communities. The College of Pharmacy also has a longstanding history of fighting to address addressing disparities in healthcare and is a leader in the fight for equitable healthcare for all individuals. This alignment in values and mission of both organizations led to the provision awarding of a grant to resulted in the College of Pharmacy being awarded a grant in 2022 to launch what we now call the McKesson Foundation Health Equity Speaker Series\, with the goal of educating the UM community and inspiring those around us to find solutions that address inequities in healthcare and beyond.\n\nAbout our Funder\, the McKesson Foundation\nThe McKesson Foundation is a charitable organization dedicated to improving health outcomes for vulnerable and underserved populations. It focuses on initiatives that address healthcare disparities\, promote patient-centered care\, and support cancer care and survivorship. Through grants\, partnerships\, and employee-driven giving programs\, the foundation aims to foster innovative solutions that enhance community health and well-being.
UID:139256-21885202@events.umich.edu
URL:https://events.umich.edu/event/139256
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Health Sciences
LOCATION:Palmer Commons - Great Lakes Room 100 Washtenaw Ave Ann Arbor, MI, 48109
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260313T102831
DTSTART;TZID=America/Detroit:20260324T100000
DTEND;TZID=America/Detroit:20260324T110000
SUMMARY:Lecture / Discussion:Access\, Ability & the Future of Pharmacy
DESCRIPTION:Date: Tuesday\, March 24\, 2026\nTime: 10:00 am – 11:00 am\nLocation: Zoom webinar\n\nDid you know that over 20% of the American population lives with a disability? Yet\, this is not reflected in the healthcare workforce\, and specifically within pharmacy where less than ~1% of pharmacists formally declare a disability. Join us for a timely conversation on why disability inclusion matters and how supporting pharmacists with disabilities leads to better outcomes for patients and the profession. Guest speakers include Dr. Lisa Meeks\, Dr. Jennifer Williams and Dr. Laura Nellen.\n\nSpeaker Bios:\n\nLisa Meeks\, PhD\, is a Professor of Medical Education at the University of Illinois College of Medicine and a global leader in disability inclusion. As founder of the Docs with Disabilities Initiative\, she has driven policy and practice advancements that reshape health professions education. Her research\, published in journals like JAMA and Academic Medicine\, focuses on equity and dismantling ableism in training. Dr. Meeks is deeply committed to creating inclusive environments where all trainees can thrive.\n\nJennifer Williams\, PharmD\, BCPS\, is a member of the American Society of Health-System Pharmacy (ASHP) and adjunct faculty member at the University of Iowa College of Pharmacy. Her primary area of practice is focused on inpatient and outpatient oncology\, and with complex inpatient surgical patients. Jennifer seeks regular opportunities to engage in education in Inclusion\, as a person living with a disability herself\, which has led to opportunities in policy writing\, webinars\, podcasts\, and a ‘forever’ drive to engage in furthering the conversation related to accessibility.\n\nDr. Laura Evelyn Nellen is a specialty pharmacist at Accredo Specialty Pharmacy\, a division of Evernorth Health Services (The Cigna Group). She specializes in providing personalized care for patients with complex conditions. Living with Spinal Muscular Atrophy Type III - a genetic neuromuscular condition causing progressive muscle weakness and mobility challenges - Dr. Nellen offers unique insights into healthcare accessibility as both a clinician and a person with physical disabilities. She advocates for inclusive practices\, health equity and patient-centered solutions to reduce disparities for disabled and chronically ill individuals.
UID:145420-21897320@events.umich.edu
URL:https://events.umich.edu/event/145420
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Health Sciences
LOCATION:Off Campus Location
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260310T095151
DTSTART;TZID=America/Detroit:20260605T080000
DTEND;TZID=America/Detroit:20260605T170000
SUMMARY:Conference / Symposium:TEAM 50th Anniversary
DESCRIPTION:NIH T32 Training Program \nTissue Engineering at Michigan \n\nSymposium: \nFriday\, June 5\, 2026\n8:00-5:00 PM\nBiomedical Science Research Building
UID:146394-21899038@events.umich.edu
URL:https://events.umich.edu/event/146394
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Health Sciences
LOCATION:Taubman Biomedical Science Research Building - Auditorium
CONTACT:
END:VEVENT
END:VCALENDAR